2. UroToday Home
  3. Video Lectures

mCRPC Treatment Videos

NCCN Guidelines Updated for Prostate Cancer M1 Systemic Therapy Based Upon Thee CARD Trial - Tanya Dorff
January 18, 2021
Details
The Progress and Promise of Prostate Cancer Treatments in 2020 - Charles Ryan & Alicia Morgans
January 7, 2021
Details
Improving Quality Imaging in Prostate Cancer with Gallium 68 PSMA-11 - Johannes Czernin
January 7, 2021
Details
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Castration-Resistant Prostate Cancer - Karim Fizazi
October 26, 2020
Details
Journal Club: Discussing Quality of Life in Patients with Metastatic Prostate Cancer Following Treatment with Cabazitaxel Versus Abiraterone or Enzalutamide - Christopher Wallis & Zachary Klaassen
October 16, 2020
Details
Treatment Considerations For Disease Progression After Combination Therapy in mCRPC - Alicia Morgans
September 29, 2020
Details
PROfound: Olaparib for Metastatic Castrate Resistant Prostate Cancer - Thomas Keane
July 2, 2020
Details
Effect of Cabazitaxel vs Abiraterone or Enzalutamide on Patient-Reported Outcomes in mCRPC: A Pre-Planned EQ-5D-5L Analysis of the CARD Study - Neal Shore
June 27, 2020
Details
Cabazitaxel Demonstrates Improved Overall Survival when Compared to an Alternative AR-targeted Agent (CARD) - Cora Sternberg
June 21, 2020
Details
The Clinical Implications of The Efficacy and Safety in Older Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel versus Abiraterone or Enzalutamide In The CARD Trial - William Oh and Stephen Freedland
June 7, 2020
Details
Rucaparib, A PARP Inhibitor For The Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Wassim Abida
June 3, 2020
Details
IMbassador250: A Study of Atezolizumab in Combination with Enzalutamide in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Christopher Sweeney
June 2, 2020
Details
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer - Rahul Aggarwal
May 16, 2020
Details
FDA Approves First PARP Inhibitor Rucaparib for Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Charles Ryan
May 15, 2020
Details
Outcomes from The PROCEED Registry: Survival of African-American and Caucasian Men After Sipuleucel-T Immunotherapy - Oliver Sartor
May 7, 2020
Details
Optimal Drug Sequencing in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Evan Yu
May 5, 2020
Details
The ORIOLE Trial Results Discussed: Outcomes of Observation vs SABR for Oligometastatic Prostate Cancer - Phuoc T. Tran
April 7, 2020
Details
Optimal Steroid Use with Abiraterone - Gerhardt (Gert) Attard
January 6, 2020
Details
Radiation Oncology Studies: Changing the Course of Disease for Men with Metastatic Prostate Cancer - Phuoc Tran
January 21, 2020
Details
Bone Health Agents in Patients with Castrate-Resistant Prostate Cancer - Bertrand Tombal
January 16, 2020
Details
Immunotherapy and Personalized Medicine in Prostate Cancer - Akash Patnaik
November 13, 2019
Details
Cabazitaxel is a New Standard of Care for Third Line Metastatic Prostate Cancer - Bertrand Tombal
October 17, 2019
Details
Personalized Medicine in Prostate Cancer - Arpit Rao
January 24, 2020
Details
Guiding First Line Treatment Decisions for mCRPC After ADT + Docetaxel or AR Pathway Inhibitor - Mary-Ellen Taplin
September 26, 2019
Details
Results and Lessons Learned from the Consensus Conference for Developing Countries - Fernando Maluf
February 2, 2020
Details
Clinical Trial Treatment Options for Rare GU Malignancies - Bradley McGregor
September 12, 2019
Details
A Study Evaluating Optimal Use of Radioactive Drugs for Prostate Cancer Therapy - Misha Beltran
August 2, 2019
Details
Radium-223 in Clinical Practice - Phillip J. Koo
August 2, 2019
Details
Decreased Fracture Rate When Adding Bone Protecting Agents to Radium-223: PEACE III- Bertrand F. Tombal
June 11, 2019
Details
Contemporary Sequencing in the Treatment of Prostate Cancer - Neal Shore, Alicia Morgans and Charles Ryan
May 31, 2019
Details
The Changing Therapeutic Landscape of Prostate Cancer- Nicholas Vogelzang
May 12, 2019
Details
Improved Survival Outcomes of African America Men with mCRPC Treated with Sipuleucel-T - Kelvin Moses
April 23, 2019
Details
Treatment Decisions for Patients with Metastatic Castration-resistant Prostate Cancer: A Retrospective Study of Real-World Experience - Tia Higano
March 27, 2019
Details
Racial Disparities in Prostate Cancer Treatment and Outcomes - Susan Halabi
February 12, 2019
Details
The Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade - Wassim Abida
January 31, 2019
Details
Introducing TIN 117m for Convention Electron Therapy of mCRPC - Suresh Srivastava
January 28, 2019
Details
An Update on the PARP Inhibitor Olaparib in mCRPC Patients: Review of the Phase 2 Results & A First Look at the Phase 3 Study.
October 28, 2018
Details
Combination Therapies and Quality of Life Data in Prostate Cancer - Fred Saad
October 11, 2018
Details
Prospective Study of Low-Dose Abiraterone with Food Versus Standard Dose Abiraterone in mCRPC - Russell Szmulewitz
May 8, 2018
Details
Exercise in Men with Metastatic Castrate-Resistant Prostate Cancer, the INTERVAL Study - Interview with Fred Saad
May 3, 2018
Details
UPWARD Study - Seizure Rates in Enzalutamide-Treated Men with mCRPC - Susan Slovin
January 6, 2018
Details